The Venus Times (Page 2)

The Venus Times

Sign in Subscribe

Venus Remedies | FICCI Healthcare Awards

Awards Featured

Venus Remedies Honored with FICCI Healthcare Awards 2023!

Venus Remedies has once again demonstrated its commitment to excellence and innovation in the healthcare industry. Your company has been recognized by the Federation of Indian Chambers of Commerce and Industry (FICCI) Healthcare Awards 2023 in the "Excellence in Patient Care and Safety" category. This prestigious award further highlights the

CPhI Barcelona 2023

Events Featured

Venus Remedies Shines at CPhI Barcelona 2023

Barcelona, Spain - 24-26 October! Venus Remedies made a significant mark at the recently concluded CPhI Barcelona 2023, a premier global event for the pharmaceutical industry. The event, held in the vibrant city of Barcelona, brought together pharmaceutical professionals, companies, and experts from around the world. Venus Remedies showcased its

Venus Remedies - Bleomycin - MA from UK MHRA

Accreditations & Approvals Featured

Venus Remedies Celebrates Market Authorization for Bleomycin 15,000 IU in the UK

Venus Remedies is thrilled to announce a significant achievement in its ongoing mission to enhance cancer care with innovative solutions. The company's German subsidiary, Venus Pharma GmbH, has secured market authorization in the United Kingdom for Bleomycin 15,000 IU Powder for Solution for Injection/Infusion, marking a remarkable milestone

Venus Remedies | CII REO

Accreditations & Approvals Featured

Venus Remedies Receives CII Responsible Export Organization Certification for the Second Consecutive Year

Venus Remedies Limited has once again been honored with the prestigious CII Responsible Export Organization (REO) certification, marking a remarkable achievement for our organization. This recognition is a testament to our unwavering commitment to responsible business practices, sustainability, and excellence in every aspect of our operations. The CII Responsible Export

Cipla collaborates with Venus | AMR

Associations Featured

The Venus & Cipla Collaboration: Pioneering the Fight Against Antimicrobial Resistance (AMR)

Antimicrobial Resistance (AMR) stands as a formidable global health threat, with the World Health Organization (WHO) ranking it among the top 10 public health concerns. In the battle against this rising menace, pharmaceutical giants Venus Remedies and Cipla have joined forces, marking a significant stride in India's fight against AMR.

Venus Remedies | Philippines

Accreditations & Approvals Featured

Venus Remedies Secures Marketing Approval for Six Key Chemotherapy Drugs in the Philippines, Expands Presence in Thriving Pharma Market

Venus Remedies has achieved a significant milestone by obtaining marketing approval for six essential chemotherapy drugs in the Philippines. This development not only bolsters the company's presence in the global pharmaceutical market but also marks a promising advancement in the fight against cancer across Southeast Asia. Venus Remedies' unwavering dedication

Venus Remedies Elores Ecuador

The Grand Launch Featured

Venus Remedies Expands Its Global Footprint with the Launch of Elores in Ecuador

In a remarkable stride towards global healthcare excellence, Venus Remedies Limited proudly announces the successful launch of Elores in Ecuador. The achievement marks a significant milestone in our journey to combat multi-drug-resistant infections. Elores, an innovative antibiotic formulation, has garnered recognition and acclaim worldwide for its groundbreaking approach to tackling

Venus Remedies Limited - Best Working Conditions Award 2022 - Haryana State Safety, Health & Welfare Awards

Awards Featured

Venus Remedies Limited Receives Best Working Conditions Award 2022

Venus Remedies Limited, a renowned pharmaceutical company based in Panchkula, was honored with the "Best Working Conditions Award 2022" on the occasion of Rajkiya Shramik Divas. This prestigious award was presented by Shri Manohar Lal Khattar, the Chief Minister of Haryana, as part of the Haryana State Safety, Health, and

VMRC - Venus Medicine Research Center

Accreditations & Approvals Featured

Venus Remedies Expands Oncology Portfolio in Eastern Europe with Serbian Marketing Approval

Bringing forth the latest update from the world of pharmaceuticals. Venus Remedies, a renowned name in the pharma industry, has recently achieved a significant milestone by securing marketing approval in Serbia for two crucial cancer drugs, gemcitabine and docetaxel. This expansion is a testament to Venus Remedies' commitment to advancing

Venus Remedies in Saudi Arabia

Accreditations & Approvals Featured

Venus Remedies Secures Marketing Approval for Enoxaparin in Saudi Arabia

In a Remarkable Milestone, Venus Remedies' Enoxaparin Prefilled Syringes Gain Marketing Approval in Saudi Arabia We are delighted to share some exciting news that underscores Venus Remedies' commitment to advancing healthcare worldwide. Venus Remedies has recently achieved a significant milestone by securing marketing approval for its Enoxaparin Prefilled Syringes in

Venus Remedies' Elores in Oman

The Grand Launch

Venus Remedies Unveils Flagship R&D Drug, Elores, in Oman

In a momentous move, Venus Remedies, a pioneer in the pharmaceutical industry, has announced the launch of its flagship Research & Development product, 'Elores', in the Sultanate of Oman. This groundbreaking product promises to set new standards in the antibiotic segment and showcases the company's relentless pursuit of innovative solutions in

Mr. Saransh Chaudhary

Publications Featured

Special Feature: Insights from Our CEO, VMRC, Mr. Saransh Chaudhary

We are thrilled to share that Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies, has been prominently featured in the Anniversary Issue of the prestigious Pharma Bio World (PBW) magazine. Highlights from the feature: 1. Reimagining Business Models: The special edition delves deep into how industry leaders

Cancer Medicine

Accreditations & Approvals Featured

Venus Remedies Bags Four More Market Authorisations for Cancer Drugs!

Hot on the heels of our recent achievements, Venus Remedies is thrilled to announce yet another significant accomplishment. We have secured market authorisations for our pioneering cancer drugs from the Philippines, Paraguay, Georgia, and Moldova. This new stride not only reinforces our commitment to spearheading global oncology solutions but also

Accreditations & Approvals Featured

Expanding Our Oncology Wing: Four Major Market Approvals

We're thrilled to announce that Venus Remedies has achieved a significant milestone in our commitment to providing top-tier oncology solutions worldwide. 🔹 Key Highlights: 1. Marketing Approvals from Four Key Markets: We have secured marketing approvals for our chemotherapy drugs from Oman, Malaysia, Bosnia, and Trinidad & Tobago. 2. These approvals mark

Business World on Antibiotics

Publications Featured

Saransh Chaudhary, President, GCC & CEO, VMRC Shares Insights on Innovative R&D in Antibiotics with Business World

In the ever-evolving medical landscape, antibiotic resistance, known as Antimicrobial Resistance (AMR), poses one of the most significant global challenges. In a testament to Venus Remedies' commitment to pioneering advancements in medical science, our esteemed President of Global Critical Care, Mr. Saransh Chaudhary, was featured in Business World's edition dated

Dr. Manu Chaudhary

Publications Featured

Meropenem: The Powerful Antibacterial Solution for Effective Treatment

Shining a spotlight on an essential antibacterial drug called Meropenem, which has revolutionized the field of medicine, this news piece brings forth a recently published article about Meropenem at TheHealthSite.com. It highlights the insightful information on the drug as shared by Dr. Manu Chaudhary, Director, Research, Venus Remedies. Meropenem,

Accreditations & Approvals Featured

Venus Remedies Secures Marketing Authorization for Meropenem in Spain

Venus Remedies Ltd. recently received Marketing Authorization (MA) to market our generic antibiotic, Meropenem, in Spain. This significant achievement marks a major milestone for the organization and reinforces our commitment to providing high-quality healthcare solutions globally. The approval from the Spanish regulator is a testament to the rigorous research, development,

NDDS | Venus Remedies

Publications Featured

Significance of Novel Drug Delivery Systems in Pharma Industry

In a recent interview with the Financial Express, Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies Ltd and CEO of Venus Medicine Research Centre (VMRC), discussed the growing significance of Novel Drug Delivery Systems (NDDS) in the pharmaceutical industry. NDDS refers to innovative techniques and technologies that

Accreditations & Approvals Featured

Venus Remedies Receives Coveted Ukrainian GMP Approval for Carbapenem & Oncology Parenteral Facilities

Venus Remedies, a leading pharmaceutical company dedicated to improving global healthcare, has achieved yet another milestone. We have recently received the prestigious Good Manufacturing Practice (GMP) approval from Ukraine for our state-of-the-art Carbapenem and Oncology Parenteral facilities at our unit in Baddi. The GMP certification is a testament to our

Accreditations & Approvals Featured

Venus Remedies Achieves GMP Certification from Kenya

Venus Remedies has received Good Manufacturing Practices (GMP) certification from the Kenya Pharmacy and Poisons Board for all its production facilities located in Baddi, Himachal Pradesh. This certification recognizes Venus Remedies' commitment to maintaining high-quality standards in manufacturing pharmaceutical products. The GMP certification is a crucial milestone for Venus as

ERA's Lucknow Medical College

Events Featured

Venus Remedies Limited Promotes AMR Solutions through Continuous Medical Education

Venus Remedies Limited, a renowned research-based pharmaceutical company, took a significant step towards combating Antimicrobial Resistance (AMR) by conducting a successful Continuous Medical Education (CME) event at the Surgery Department of ERA's Lucknow Medical College on May 17th, 2023. During the CME, esteemed doctors and medical professionals gathered to discuss

Engagements Featured

Venus Remedies Limited Collaborates with KGMU Neurosurgery Department for Groundbreaking Medical Education Program

In a significant stride towards advancing medical knowledge and fostering collaboration, Venus Remedies Limited recently participated in a Continuing Medical Education (CME) program at the renowned King George's Medical University (KGMU) in Lucknow. The event, organized in conjunction with the esteemed Neurosurgery Department, aimed to shed light on the vital

Venus Remedies in Iraq & Philippines

Accreditations & Approvals Featured

Venus Secures Marketing Authorization for Cancer Drugs from Iraq & Philippines

Venus Remedies has recently achieved a significant milestone by obtaining marketing authorizations for two of its groundbreaking cancer drugs in Iraq and Philippines. This recent development not only underscores the company's commitment to improving global healthcare but also highlights its growing presence in the Middle East. Venus Remedies has long

CK Birla Hospital

Events Featured

Venus Conducts Hospital CME Activity on World Hand Hygiene Day

Venus, an organization dedicated to patient welfare, showcased its commitment to promoting hand hygiene in healthcare settings through a recent Continuing Medical Education (CME) activity. Held on 5th May 2023 at CK Birla Hospital in Jaipur, the event proved to be a resounding success in raising awareness about the criticality

Cancer Fight in Ukraine

Accreditations & Approvals Featured

Venus Remedies' Oncology Portfolio Extends to Ukraine, Empowering the Fight Against Cancer

Thrilled to share a remarkable achievement by Venus Remedies, as it proudly expands its global footprint in the field of oncology. With a recent contract win in Ukraine, Venus Remedies has taken a significant step towards combating cancer in a nation ravaged by war. This momentous occasion signifies our commitment